MAM
MediaCom named world’s top media agency by RECMA
MUMBAI: RECMA, the independent research organization charged with the in-depth assessment of global media agency network performance has recognized MediaCom as the world’s top media agency.
The results were published this week in RECMA’s authoritative Network Diagnostics report, with MediaCom ahead of Carat, OMD and Starcom across 19 key qualitative metrics designed to measure agency vitality and structural ability to address today’s complex communications challenges.
MediaCom’s top position is underpinned by its recent new business success across a number of networked clients, with marquee client wins including Mars worldwide planning, The Coca-Cola Company assignment in Mexico and the AB Inbev account in the US. Momentum in the US, the largest market for all players in the industry, has resulted in MediaCom being named 2015 US Media Agency of the Year by both Advertising Age and Adweek.
The full RECMA qualitative assessment is based on MediaCom’s performance across 40 markets in not only pitch competitiveness, but also client loyalty, top management, digital resources and awards, reflecting the agency’s proven performance in delivering superior results for global clients such as the Coca-Cola Company, Procter and Gamble and Sony.
“We’ve worked incredibly hard over the last few years to consistently build the global scale and expertise it takes to commit 100 per cent to all our clients while still winning new business. With more brands looking to marketing to drive business growth, our Content + Connections positioning and systems thinking approach enables us to provide a unique level of guidance and maximize client shareholder return,” said MediaCom worldwide chairman and CEO Stephen Allan.
MAM
Beacon Group appoints Dr Rajesh Patel as Group CEO
36-year healthcare veteran to lead Beacon Diagnostics, Vector Biotek, Biogeny.
MUMBAI: A new chief, a fresh diagnosis and a sharper prescription for growth. Beacon Group has appointed Dr Rajesh Patel as its Group Chief Executive Officer, effective April 1, 2026, signalling a decisive push to scale its presence in the diagnostics and IVD space. Patel steps into the role with 36 years of experience across the healthcare and diagnostics industry, bringing a career shaped by leadership roles spanning sales, marketing, business development and operational strategy. His mandate is both expansive and precise: to steer the group’s overall strategic direction while tightening coordination across its three core entities Beacon Diagnostics, Vector Biotek and Biogeny Diagnostics.
In practical terms, that means driving cross-company synergies, accelerating market expansion and strengthening organisational capability areas increasingly critical as diagnostic players compete for scale in a fragmented yet rapidly evolving healthcare ecosystem. The group is positioning itself to capture unmet demand across chain laboratories, key accounts and standalone labs, segments that remain underserved despite growing diagnostic needs.
The appointment comes at a time when the In Vitro Diagnostics (IVD) sector in India is entering a more competitive and innovation-led phase, with companies focusing not just on product pipelines but also on service delivery, integration and customer-centric models. Beacon’s leadership appears to be betting that Patel’s execution-focused approach can help translate ambition into operational momentum.
Welcoming the appointment, Chairman Dr D K Joshi described Patel’s induction as a strategic move aligned with the group’s long-term vision, emphasising the role of leadership depth in navigating the next phase of growth.
For Beacon Group, the message is clear, in a sector where precision matters, leadership is the new differentiator—and this appointment is intended to set the tone for what comes next.
